Ebos GroupASX:EBO +3.13%77 EBIT per Share is A$1.96 as of Dec. 2025. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$33.68 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 105 Medical Distribution companies, Ebos Group ranks worse than 59.05% on this metric.
Ebos Group's EBIT per Share for the
six
months ended in Dec. 2025 was A$1.03.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.96.
During the past 12 months, the average EBIT per Share Growth Rate of Ebos Group was -16.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 1.10% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 7.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 8.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Ebos Group's EBIT per Share or its related term are showing as below:
ASX:EBO'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -54.2 Med: 9.05 Max: 52.3
Current: 1.1
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ebos Group was 52.30% per year. The lowest was -54.20% per year. And the median was 9.05% per year.
ASX:EBO's 3-Year EBIT Growth Rate is ranked worse than 59.05% of 105
companies
in the Medical Distribution industry
Industry Median: 4.2
vs ASX:EBO: 1.10
Ebos Group's EBIT for the
six
months ended in Dec. 2025 was A$211 Mil.
Ebos Group (ASX:EBO) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Ebos Group EBIT per Share Related Terms
Ebos Group EBIT per Share Historical Data
* Premium members only.
The historical data trend for Ebos Group's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.96
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a EBIT per Share of A$1.96 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ebos Group and its competitors. According to the industry distribution chart, Ebos Group ranks #62 out of 105 companies in the Medical Distribution industry, placing it in the top 59%.
Is Ebos Group's EBIT per Share too high?
Ebos Group's current EBIT per Share is A$1.96. Based on the distribution chart, Ebos Group ranks #62 out of 105 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's EBIT per Share compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #62 out of 105 companies for EBIT per Share. This places Ebos Group in the lower half of its industry. The industry median EBIT per Share is 4.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Distribution company?
The median EBIT per Share among Medical Distribution companies is 4.20, based on 105 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median EBIT per Share is 4.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current EBIT per Share is A$1.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$33.68, compared to a current price of A$17.47 — trading 48.1% below its estimated fair value. The current EBIT per Share is A$1.96. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current EBIT per Share is A$1.96 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$17.47 is trading 48.1% below its estimated GF Value™ of A$33.68.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
EBIT per Share: A$1.96
GF Value™: A$33.68 vs. price of A$17.47 (48.1% below fair value)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
